Accel Instruments and GSI (Gesellschaft fur Schwerionenforschung) are partnering with Siemens Medical Solutions to develop technology for delivering particle therapy. Accel, headquartered in Bergisch Gladbach, Germany, has more than 20 years' experience
Accel Instruments and GSI (Gesellschaft fur Schwerionenforschung) are partnering with Siemens Medical Solutions to develop technology for delivering particle therapy. Accel, headquartered in Bergisch Gladbach, Germany, has more than 20 years' experience in particle accelerator technology. GSI is a government-funded heavy ion research center located in Darmstadt, Germany. Particle therapy treatments utilize fast-moving atomic particles such as ions or protons. Treatments can be focused with pinpoint accuracy, thereby lowering integral dose and reducing toxicity to healthy tissues.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.